Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propylene Glycol in Acetaminophen Dosing
NCT02322879Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propylene glycol in Liver injury (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Rise in Plasma Transaminases: Proportion of Responders. Started May 2013; status: completed.
02
Drugs
propylene glycol
03
Conditions
Liver injury
Beyond the preview
Go deeper on NCT02322879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322879.